CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- S-3ASR Offering Registration Statement
- S-3ASR Offering Registration Statement
- 4 Insider Changes in Ownership
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 4 Open-market sale EVP & CFO sold 38,291 shares at $125.50 ($4,805,521)
- 4 Open-market sale Chairman, CEO & President sold 235,021 shares at an average $125.69 ($29,538,998)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale President, Human Health Int?l sold 1,000 shares at $124.89 ($124,888)
- SC 13G/A Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Executive VP & President, MRL sold 14,702 shares at $125.50 ($1,845,083)
- 144 Insider Sale of Securities
- 4 Open-market sale EVP,Chief Info&Digital Officer sold 1,451 shares at $127.57 ($185,108)
Page 17 of 152 · 3,038 filings